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In the present work, we analyzed how external factors can modulate the efficiency of 
epigallocatechin-3-O-gallate (EGCG) inhibition of a membrane-bound isoform of the 
acetylcholinesterase. Increasing the ionic strength but not the osmolarity of the bulk 
medium proved to be an important factor. In addition, we verified a clear correlation 
between the inhibitory activity with the order degree of the membranes by using 
cholesterol-partially depleted red blood cell ghosts. These two factors i.e. high salt 
concentration in the bulk medium and less viscous membranes, allow a deeper 
insertion of the EGCG into the lipid bilayer, thus leading to a greater inhibition of AChE. 
As a corollary, we propose that any treatment or process that leads to a slight decrease 
in cholesterol content in the membranes can efficiently enhance the inhibitory activity of 
EGCG, which can have important consequences in all the pathologies where the 
inhibition of AChE is recommended.  
 
 

















Acetylcholinesterase (AChE) is a serine hydrolase involved in the termination of cholinergic 
neurotransmission. The three main variants of AChE formed by alternative splicing share a 
common core of 543 amino acids and differ in their C-terminal sequences as well as in their 
cellular localization and subunit structures. AChE-S, the “synaptic” form, is the principal variant 
present in brain and muscle tissues. It may be present as four AChE-S monomers that are 
covalently linked to a three-stranded collagen-like tail (ColQ) to form a basal lamina-anchored 
tetramer at the neuromuscular junction. Even more, three of these tetramers could hybridize to 
make “asymmetric” dodecamers bound to membranes. Besides ColQ, the protein called PRiMA 
can also interact with AChE. Indeed, it attaches the S-derived tetramers to plasma membranes 
in cells [1]. In addition to AchE-S, the “readthrough” monomeric form (AchE-R), is expressed in 
embryonic and tumor cells and induced in response to psychological stress and AChE 
inhibition. Finally, the “erythrocytic” variant that is referred as AChE-E, forms dimers and is 
linked to red blood cells (RBC) membranes by a glycosylphosphatidylinositol anchor (GPI) [2]. 
Acetylcholinesterase inhibitors (AChEI) are clinically used to counteract various pathologies 
including myasthenia gravis, autoimmune autonomic ganglionopathy, postural tachycardia 
syndrome and the most notorious one, Alzheimer’s disease. Treatment with these compounds 
may alleviate symptoms by enhancing cholinergic functions and increasing the amount of 
acetylcholine present in cholinergic synapses.  In addition to the classical role in modulating 
nerve impulse, non-cholinergic functions have been proposed, some of which may involve 
protein–protein interactions [3]. In Alzheimer’s disease, the hypothesis that AChE might bind β-
amyloid and promote its deposition has been suggested [4]. Several compounds have been 
approved for the symptomatic treatment of these diseases. However, synthetic AChE inhibitors 
such as physostigmine, tacrine and donepezil have been reported to have adverse effects. 
Actually, tacrine that was the first inhibitor of its kind was discontinued some years ago [5,6]. 
Parkinson’s disease patients may also benefit from AChE inhibitors [7]. Last but not least, 
AChEI were proposed as a tool for combating leishmaniasis, a disease that globally affects 
millions of people. Leishmania braziliensis, the major etiologic agent cannot synthesize choline, 
















of the parasite may be affected by inhibiting AChE activity [8–10]. Thus, there is a big interest in 
the development of new AChE inhibitors and among other compounds, polyphenols have 
emerged as promising candidates [11]. 
Polyphenols are plant metabolites with phenolic groups in their structures. A number of health 
benefits have been described for polyphenols so far. Many of these compounds are well-known 
as potent antioxidants and strong metal chelators. However, they are not antioxidants just 
because they scavenge reactive oxygen species but instead they can protect from oxidative 
stress because they may activate signaling pathways and key protective enzymes [12]. 
Antimicrobial properties as well as antiallergic and anti-hypertensive activities have also been 
described. In addition, due to their abilities to inhibit ABC transporters associated to the efflux of 
xenobiotic compounds, anti-cancer properties were also reported [13,14]. 
Polyphenols were shown to interact not only with proteins but also with membrane lipids [15,16], 
which in turn may be associated with some of the activities mentioned above. For instance, we 
demonstrated that the stilbene resveratrol enhanced ABCG1 ATPase activity in a non-
transcriptional way by interacting with the lipid bilayer where ABCG1 was inserted [17]. In the 
same trend, we were able to show that epigallocatechin-3-gallate (EGCG), a flavan-3-ol that is 
the major constituent of the green tea, interacted with the surface of both liposomes and human 
erythrocytes, thus enhancing its inhibition of AChE-E. Actually, resveratrol and EGCG had 
already been described as AChE reversible inhibitors and at the same time leishmanicidal 
agents [8,18]. Our main contribution was to show that EGCG was more efficient as AChE 
inhibitor when the enzyme was bound to membranes as compared to its soluble form. In fact, 
AChE-E has proved to be a good model for studying the enzymatic activity of membrane-bound 
AChE isoforms [19], hence this variant was chosen to carry out the present work. 
The activity of AChE as well as the activities of a number of membrane-bound enzymes have 
been shown to depend on the membrane lipid composition and membrane order [20–23]. That 
is to say, membrane lipid alterations may induce changes in the activities of membrane-bound 
enzymes. The cholesterol content of RBC membranes is in equilibrium with unesterified plasma 
cholesterol, which is regulated by the enzyme lecithin-cholesterol acyltransferase [6,24]. Hence, 
















may lead to alterations in plasma cholesterol levels and subsequently to alterations in 
cholesterol content of erythrocyte plasma membranes [25]. 
As commented above, we recently demonstrated that EGCG did inhibit AChE-E and it was 
more active on the membrane-bound enzyme. In our hands, EGCG did not get inserted into the 
lipid bilayer under the conditions tested. On the contrary, Cyboran et al. showed that EGCG 
may enter the hydrophobic core of membranes when isotonic buffers were used, unlike our 
experiments that were carried out in hypotonic buffer [26]. On this point, Kajiya et al. 
demonstrated that the incorporation of green tea catechins into lipid bilayers is stimulated by the 
increase of salt concentration and inhibited by the increase of negative charge of lipid bilayers 
[27]. Therefore, in the present work we studied the influence of the ionic strength on the AChE 
inhibition by EGCG. In other words, we aimed to know if the localization of EGCG in the 
membrane had influence on the degree of AChE inhibition. At the same time, since EGCG 
interacts with model membranes in a way dependent on the cholesterol content, i.e. the lower 
the cholesterol content in the membrane, the deeper it gets inserted, we analyzed the inhibition 
of AChE upon addition of EGCG when cholesterol level in erythrocyte membranes was 
reduced. 
2. Materials and Methods 
2.1. Reagents 
Acetylthiocholine iodide (ATC), epigallocatechin-3- gallate (EGCG), quercetin, Triton X-100 and 
methyl-β-cyclodextrin (MβCD) were purchased from Sigma-Aldrich, Argentina. EGCG was 
dissolved in methanol, kept under nitrogen at -20ºC and its concentration was routinely checked 
by the Folin method, with quercetin as standard [28]. 5, 5’ -dithiobis-2- nitrobenzoic acid (DTNB) 
was purchased from ICN, octadecyl rhodamine B chloride (R18), N,N,N-trimethyl-4-(6-phenyl- 
1,3,5-hexatrien-1-yl) phenylammonium p-toluenesulfonate (TMA-DPH), and 1,6-diphenyl-1,3,5-
hexatriene (DPH) were purchased from Life Technologies, Argentina. Fluorescent probes were 
prepared as methanolic solutions and stored at -20ºC. All other reagents were of the highest 
purity grade commercially available. 
















Human blood was obtained by venous puncture using Na2EDTA as anticoagulant (1 mg/mL 
blood) from healthy volunteers, residents of San Miguel de Tucuman (Argentina), after giving 
informed consent and signing consent documents according to our Institutional Ethics 
Committee. Blood samples were centrifuged (2,000 x g, 10 min), plasma and white cells were 
discarded and erythrocytes were washed with 10 volumes of 0.9% NaCl three times. 
Afterwards, erythrocytes were lysed with 30 volumes of hemolysis buffer (5 mM phosphate 
buffer, pH 7.4, containing 1 mM Na2EDTA). Hemoglobin-free membranes or “ghosts” were 
obtained by repeated centrifugations at 10,000 x g, 20 min each cycle. All steps were performed 
at 0 - 4ºC. Even though ghosts can preserve full acetylcholinesterase activity for nearly 2 
months when stored at 4ºC [20] , they were used within a week. 
The solubilization of AChE from erythrocyte membranes was carried out by diluting membrane 
suspension 20 times with the same buffer containing the non-ionic detergent Triton X-100 at a 
final concentration of 0.04%. After gently mixing for 15 min at room temperature, the sample 
was centrifuged for 1 h at 10,000 x g at 4ºC and the pellet was discarded [29]. Cyclodextrins, 
oligomers of glucose, are widely known for the ability to solubilize lipids through the formation of 
molecular inclusion complexes. Particularly, methyl-beta-cyclodextrin (MβCD) is able to extract 
and solubilize cholesterol, among other molecules from biological and synthetic membranes 
[30,31]. The extraction of cholesterol from RBC membranes was performed by incubating equal 
volumes of ghost suspension and different concentrations of MβCD solution (3 mM and 0.75 
mM of MβCD in 5 mM Tris-HCl buffer, pH 7.4) for 15 minutes at 37ºC with gently mixing. After 
this, cholesterol-depleted ghosts were obtained by repeated and exhaustive washing with 5 mM 
Tris-HCl buffer, pH 7.4 and centrifugation at 10,000 x g 20 min. All steps were performed at 0 - 
4ºC. 
2.3. Acetylcholinesterase inhibition by EGCG 
The inhibition of AChE-E activity by EGCG was determined by the Ellman’s method, using ATC 
as a substrate [32]. Briefly, ghost membranes, cholesterol-depleted ghosts and solubilized 
samples were diluted in different buffers (hemolysis buffer, hemolysis buffer containing 150 mM 
NaCl, hemolysis buffer containing 300 mM NaCl and hemolysis buffer containing 300 mM 
















preincubated for 15 minutes at 37ºC. For control reactions, the addition of EGCG was replaced 
with the same volume of methanol. ATC was then added to the mixture and absorbance of the 
5-thio 2-nitrobenzoate that was being produced was measured at 412 nm with a 10-sec 
intervals for 3 min at 37°C in an automated microplate reader (SpectraMax Plus 384). Parallel 
reactions performed without enzyme and/or without substrate were used to correct absorbance 
readings.  
2.4. Fluorescence spectroscopy. Analysis of EGCG interaction with membranes 
Possible changes in membrane order or fluidity induced by EGCG were estimated by steady-
state fluorescence anisotropy using the fluorescent probe DPH. In this case, membrane fluidity 
refers to the degree in which phospholipid acyl chains conformation vary during the lifetime of 
the excited state of the probe i.e. DPH inserted into the hydrophobic core of the lipid bilayer 
[33]. Any interaction of EGCG with the hydrophobic core of the membrane bilayer would 
translate into changes in the membrane order that in turn might be detected as variations in the 
anisotropy values of DPH.  
Fluorescent probes were added under constant vortexing to membrane suspensions in 
hemolysis buffer, in a 1:800 probe:phospholipid molar ratio. Samples were incubated at room 
temperature for 30 min in the dark. Fluorescence measurements of control conditions and 
treated samples with 100 µM EGCG were carried out using an ISS PC1 spectrofluorometer, L-
format equipped with a thermostatized cuvette holder The steady-state DPH fluorescence 
anisotropy was determined adjusting the excitation and emission wavelengths at 350 and 450 
nm, respectively. Steady-state anisotropy (r) was measured by using excitation and emission 
polarizers, and r was automatically calculated by the Vinci software (ISS). In addition to 
anisotropy values, total fluorescence intensities were also recorded, looking for possible 
quenching of the DPH fluorescence as another way to detect interactions of EGCG with red 
blood cell membranes [34,35]. Each measurement was done in triplicate. 
Besides, for assessing the possible binding of EGCG to the phospholipid head groups at the 
erythrocyte plasma membrane, quenching of the R18 fluorescence was measured upon 
















at a 1:1,000 probe:phospholipid final molar ratio, in which high fluorescence intensity was 
achieved. R18 fluorescence emission spectra were recorded upon addition of EGCG from a 1 
mM stock solution. Fluorescence measurements were carried out in an ISS PC1 
spectrofluorometer equipped with a thermostatic cuvette holder set at 37ºC. Excitation 
wavelength was set at 520 nm (16 nm slit), while the emission spectra were taken from 550 nm 
to 650 nm (16nm slit). 
2.5. Fourier-transform infrared spectroscopy analysis (FTIR) 
As a first step, ghost membrane preparations were lyophilized in order to remove the 
water and then resuspended in deuterated water. Afterwards, FTIR absorption spectra 
of ghosts membranes, before and after the treatment with MβCD were collected in 
transmission mode, using a demountable liquid cell (Harrick Sci, NJ, USA) equipped 
with calcium fluoride windows and 56 μm PTFE spacers. The temperature of the cell 
was controlled by means of a circulating water bath and a custom made thermocouple 
for measuring the temperature of the cell. Measurements were undertaken in a Nicolet 
5700 spectrometer (Thermo Nicolet, Madison, WI) equipped with DTGS detector, 
operated by the software provided (OMNIC) at 2 cm−1 spectral resolution and 
averaging 64 scans. For our experiments, approximately 20 μl of sample was 
deposited on the cell, equivalent to 20 mM of phosphate in the sample. Spectra of the 
buffer were obtained using the same conditions as the samples, in order to eliminate 
any signal attributable to buffer components by spectra subtraction. The spectra were 
analyzed by second derivative methods using NRC software in order to obtain the 
component bands. Band fitting was routinely carried out with SpectraCalc. The order of 
the hydrophobic core was assessed by following the evolution of the wavenumber of 
symmetric stretching of methylene (circa 2850 cm−1) with temperature. The hydration 
level of the interfacial region of the membranes was studied by fitting the contribution of 
















mode (circa 1740 cm−1). To verify the reproducibility and reliability of the spectral 
results, three independent ghosts preparations were analyzed. 
2.6. Miscellaneous  
Phospholipid concentration in membranes was estimated by the Ames method [37]. Protein was 
determined by the Bradford assay [38]. Cholesterol concentration in membranes was 
determined using a commercially available kit (Colestat enzimatico, WienerLab, Argentina). 
3. Results 
3.1. Acetylcholinesterase inhibition by EGCG.  
EGCG inhibited the activity of the membrane-bound form of AChE-E at the concentrations 
tested. As can be seen in Fig. 1, a greater inhibition was observed upon increasing salt 
concentration, attributable to ionic strength because no significant change in inhibition was 
detected with the increase in osmolarity obtained with mannitol. However, the solubilized AChE-
E displayed a different pattern since no correlation between the inhibition of soluble AChE-E 
and the ionic strength was observed. This result may be related to the greater membrane 
insertion of EGCG when buffer contains more salt as it was proposed by Cyboran et al. (see 
discussion and below) [26]. 
As it was demonstrated by our group in a previous work [15], cholesterol content of model 
membranes also influences EGCG localization in the lipid bilayer. The lower the cholesterol 
content the deeper localization in the membrane of the polyphenols. The different penetration of 
EGCG in membrane ghost may affect the way it interacts with the AChE-E. Thus, the 
cholesterol content of ghosts was decreased by treating them with increasing concentrations of 
MβCD. Cholesterol content was routinely checked after each treatment by a colorimetric assay 
based on cholesterol oxidase method (Table 1). The inhibition of AChE-E bound to ghost 
membranes containing different cholesterol levels is shown in Fig. 2. The reduction in 
cholesterol content did enhance the inhibition of the enzymatic activity by EGCG. This result led 
us to propose that the reduction of membrane cholesterol content might allow EGCG to have a 
















3.2. Modulation of membrane order degree in the presence of EGCG 
The fluorescent probe DPH was used to label the hydrophobic core of the lipid bilayer allowing 
the detection of any change in the order degree of this region by measuring the fluorescence 
anisotropy. As a first step, the ionic strength of the bulk medium was modified by adding NaCl to 
the working buffer. When ghosts were suspended in a hypotonic NaCl-free buffer, EGCG 
slightly changed the ordering of membranes. However, if ghosts were suspended in 150 mM 
NaCl, a reduction of the anisotropy of control membranes was observed. The addition of EGCG 
reversed this reduction, inducing an increase of the membrane order, strongly suggesting an 
important interaction between this polyphenol and the lipid bilayer. Since the enhancement of 
EGCG effect had been found to be more evident at 300 mM NaCl, this concentration of salt was 
also tested. Even though there was no change in the membrane order in this condition in the 
absence of polyphenol as compared to the control, a more pronounced increase of the 
anisotropy was detected upon addition of EGCG (Fig. 3A and 3B). As expected, MβCD 
treatment did lower the membrane order as compared to untreated membranes. The addition of 
EGCG to cholesterol-partially depleted ghosts increased the DPH fluorescence anisotropy 
values (see Fig. 4A and 4B). The cholesterol extraction from ghosts allowed a deeper 
penetration of EGCG beyond the interphase and well into the hydrophobic core, as discussed 
below. Probably, due to its structure, EGCG displayed an ordering/ rigidifying effect on these 
membranes.  
3.3. Association of EGCG to erythrocyte membrane surface 
For evaluating the possible binding of EGCG to the phospholipid head groups at the 
erythrocyte plasma membrane, quenching of the R18 fluorescence was measured 
upon addition of EGCG. The localization of the probe is such that the rhodamine head 
group situates at the interfacial region while the hydrocarbon moiety penetrates into the 
hydrophobic core of the membrane [39]. 
The addition of NaCl was an important factor that allowed a more efficient quenching of 
the R18 fluorescence upon addition of EGCG. In this way, it is clear that this catechin 
















strength was higher (Fig 5A). As a control, R18 fluorescence quenching was also 
tested with an AChE-solubilized form. No changes in fluorescence was detected in the 
whole range of EGCG concentrations studied (data not shown).  
The R18 measurements were repeated with membranes containing lower 
concentrations of cholesterol. As it can be observed from Fig. 5B, the degree of 
quenching was related to the cholesterol content, i.e. the lower the cholesterol content, 
the higher the quenching of R18 fluorescence. Once again, it can be proposed that a 
lower cholesterol content in membranes may allow an enhanced penetration of EGCG 
in the lipid bilayer. In this way, the R18 dye becomes more accessible to EGCG which 
acts as the quencher, resulting in higher values of KSV. 
The incubation with either NaCl or MβCD might induce a differential release of proteins 
from ghosts, which in turn could potentially affect the extent of binding and insertion of 
EGCG. Therefore, the possible release of proteins was studied. Even though some 
proteins were solubilized from the membranes upon incubation during the time frame of 
the experiment, the bands observed in the SDS-PAGE were the same in all cases and 
the percentage of protein released from the ghosts was similar under all the conditions 
tested (approximately 5% of total ghost protein). Besides, no correlation between the 
released protein concentration and the EGCG effect on AChE was found 
(Supplementary information, Fig. S1 and Table S1). More importantly, the incubation 
with MβCD and/or NaCl did not released AChE from the ghosts. In fact, no AChE 
activity was found in the filtrates since TNB-2 anion was not generated from DTNB even 
after incubation times as long as 2 h. This result indicates that the greater binding and 
insertion of EGCG to erythrocyte membranes in the presence of increasing 
concentrations of NaCl or upon partial depletion of cholesterol are not due to significant  
loss of proteins from cytoskeleton or other membrane-associated proteins. 
















We studied the IR spectra of ghosts before and after cholesterol extraction with MβCD 
and before and after the treatment and pre-incubation with EGCG. As shown in Fig. 6 
A, the FTIR absorption spectra of both ghosts are complex since samples include a 
variety of molecules such as mix of different lipids, proteins, carbohydrates and, when 
added, the catechin itself. As indicated in Fig. 6A, the stretching vibrations of 
methylene and methyl groups of phospholipid hydrocarbon tails dominate the spectral 
range of 3,050–2,800 cm−1, whereas ester carbonyl absorption of lipids is detected 
around 1,740 cm−1 [40,41], and the Amide I band of proteins dominates the spectrum 
between 1,700 and 1,600 cm−1 (C=O stretching and the NH bending of the peptide 
bond) [42,43]. Even though the Amide I band is sensitive to the protein secondary 
structure, no interpretation was made in the present work because of the wide range 
and number of different membrane proteins present in the membrane of erythrocytes. 
The analysis of the infrared spectra revealed that EGCG perturbs membrane properties 
in ghosts with low cholesterol content. The detection of these changes became evident 
after the analysis of the second derivative spectra, which allowed the resolution of the 
overlapping components of the IR absorption bands. As lipid absorption in the mid IR 
was very complex since many different lipid moieties were also involved, we focused 
on the absorption of methylene and methyl stretching (at ~2,921, 2,851 cm−1) and 
carbonyl stretching (at ~1,740 cm-1) vibrational modes. 
Table 2 shows that the CH2 symmetric stretching vibration significantly changed after 
the treatment with EGCG. In particular, the down-shift in ghosts treated with MβCD, 
from 2,851.4 to 2,850.93 cm−1, indicates that a higher degree of acyl chain packaging is 
induced by the presence of EGCG. This effect was lower in the case of untreated 
ghosts, i.e. with normal level of cholesterol. These results are in agreement with the 
fluorescence anisotropy measurements commented above. At first sight, the ordering 
of the low cholesterol ghosts by EGCG does not seem to be an important change in the 
















However, this change is in the same order of magnitude than those observed in control 
ghosts and in ghosts treated with MβCD in the absence of EGCG, when temperature 
increases from 15 to 45ºC (see Supplementary information, Fig. S2). Thus, EGCG 
exerts a greater perturbation on the degree of packaging of phospholipid tails when 
cholesterol level is lower. Surprisingly, despite the fact that EGCG perturbs the 
hydrophobic core of the lipid bilayer, only minor changes on the hydration level of the 
interfacial region of ghosts membranes was observed, as slight increase in the 
contribution of hydrogen compared to non hydrogen-bounded carbonyl groups to the 
stretching vibrational mode (see Supplementary Information, Table S2) was obtained. It 
can be proposed that hydroxyl groups from the catechin may replace water molecules 
as hydrogen donors, as the highest increase is in the presence of EGCG in cholesterol 
depleted ghosts. The detection of these changes became evident after the analysis of 
the second derivative spectra, since it allowed the resolution of the overlapping 
components of the IR absorption bands by undertaking curve fitting. 
Apart from that, what was even more interesting was the finding of a band in the 
spectra attributable to the EGCG. This band, placed at approximately 1,700 cm-1 was 
assigned as the carbonyl stretching vibration mode of the EGCG (see Fig. 6C and Fig. 
6E) [44]. The position of such band in samples containing EGCG and membranes is 
shifted towards higher wavenumbers from its position when compared to EGCG alone, 
either dried or hydrated with D2O (see Fig. 6F). Therefore, the catechin carbonyl 
groups are non-hydrogen bonded in the presence of red cell ghosts, confirming that 
EGCG readily partition into membranes. 
4. Discussion 
In the present work we demonstrated that the inhibition of the AChE activity by EGCG 
could be modulated by the ionic strength. In fact, not only the degree of inhibition by 
















As a matter of fact, this latter finding is in agreement with several reports in the 
literature that described how salts can enhance the activity of AChE from various 
sources [45, 46]. The substrates acetylcholine and acetylthiocholine are cationic 
compounds, while the active site of AChE has several anionic residues. Therefore, 
salts can modulate the interaction of them and ultimately the kinetics of the reaction. 
Besides the considerations of the charges in the enzyme itself, it is tempting to 
speculate that salt bridges that are formed between some membrane components and 
the enzyme may reduce the activity when working at low salt concentrations. On the 
contrary, increasing the NaCl to physiological levels may disrupt those interactions and 
let the enzyme work in full activity. Actually, it had been reported that AChE can form 
self-aggregates in media with low salt concentrations [45]. Furthermore, Wille et al. 
have found that the buffer system used for measuring AChE activity can be a major 
factor that determines the efficiency by which this enzyme hydrolyzes its substrate [47]. 
EGCG is not a charged molecule, thus the direct association of this polyphenol with 
AChE would not be influenced by the ionic strength. However, the stronger interaction 
of EGCG with membranes when salt concentration is raised could allow this flavonoid 
to approach more efficiently to AchE-E. When the enzyme was solubilized upon 
addition of Triton X-100 a higher activity was also seen, but no greater inhibition was 
observed in the presence of EGCG. Therefore, these two events are independent from 
each other.  
The addition of EGCG slightly increased the order of the membranes in control ghosts 
and this effect was more pronounced when NaCl was present. It may be reasonable to 
speculate that a better membrane insertion can help EGCG to interact more efficiently 
with the enzyme. On the contrary, an indirect inhibition of AChE because of the 
changes in the membrane order induced by EGCG could be ruled out. In fact, it has 
















affect the activity itself but only the allosteric properties of non competitive inhibition 
[23]. 
In addition, since cholesterol is a well-known modulator of the membrane order, we 
decided to study the possible inhibition of AChE by EGCG in membranes containing 
lower concentrations of cholesterol. We found that the lower the membrane order the 
greater the inhibition measured, which was correlated with a greater insertion of EGCG 
in membranes, as it could be inferred from the increased fluorescence anisotropy that 
was induced by EGCG in partially-depleted cholesterol membranes. We hypothesize 
that any change that leads to efficient interaction/insertion of EGCG with membranes 
will enhance the inhibition of AChE. It has been previously reported that cholesterol 
content of red blood cells is in equilibrium with free cholesterol in plasma [6,24,48], thus 
any therapy or regime that lowers cholesterol may have an impact on the inhibitory 
activity of EGCG. The central nervous system has an independent pool of cholesterol 
that does not depend on the diet but it may be altered by some drugs like the statins, 
which inhibit the endogenous synthesis of cholesterol [48]. Even though it has been 
demonstrated that statins do not alter AChE activity [49], the results presented in this 
manuscript may suggest that a combination of statins and polyphenols such as EGCG 
can be of interest in the palliative treatment of Alzheimer’s disease, because only little 
changes in cholesterol would be needed for enhancing the EGCG inhibitory activity. 
However, in vivo and clinical studies will be needed in order to corroborate the efficacy 
of such combinations. 
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Table 1. Cholesterol depletion by MβCD 
 
 








control 4.80 ± 0.19 5.00 ± 0.20 6.70 ± 0.33 1.40 ± 0.12 1.34 ± 0.12 
MβCD 
0.75 mM 
4.40 ± 0.22 4.00 ± 0.16 5.30 ± 0.18 1.20 ± 0.10 1.32 ± 0.10 
MβCD 
3 mM 

















Table 2. Position of the symmetric and asymmetric stretching vibrational mode of ghost 
membranes with different cholesterol content and treated with EGCG 
 
 Wavenumber [cm-1] 
Sample ν symmetric CH2 ν asymmetric CH2 
Ghost Control 2851.7 2922.9 
Ghost Control + EGCG 2851.5 2922.4 
Ghost MβCD 2851.4 2922.4 




















Fig. 1. EGCG inhibition of acetylcholinesterase is enhanced by ionic strength. The membrane-
bound form (A) and the solubilized form (B) of AChE-E were diluted in working buffer containing 
either 0 mM, 150 mM, 300 mM NaCl or 300 mM mannitol, as described in Materials and 
Methods and erythrocyte acety-cholinesterase activity was measured by Ellman´s method in the 
presence (gray bars) or the absence (black bars) of 100 µM EGCG. Experiments were 
performed at least three times and in triplicate; values are expressed as mean ± standard 
deviation. 
 
Fig. 2. Inhibitory activity of EGCG is also influenced by membrane cholesterol content. RBC 
ghosts were treated with either 0, 0.75 mM or 3 mM MβCD, as described in Materials and 
Methods. After that, cholesterol content was measured in each sample (table S1). Finally, 
AChE-E activity was assessed by Ellman’s method in the presence (gray bars) or the absence 
(black bars) of 100 µM EGCG. The shown values are mean ± standard deviation and were 
determined at least three times and in triplicate. 
Fig. 3. Membrane order is increased upon interaction with EGCG with ghost membranes. 
Erythrocyte ghosts were labeled with the fluorescent probe DPH and diluted in working buffer 
containing either 0 mM, 150 mM and 300 mM NaCl (plain bars), then EGCG was added to a 
final concentration of 100 µM (stripped bars) and DPH fluorescence anisotropy (r) was 
measured at 37ºC (A). For clarity, the Δpolarization (Δp) is also shown (B), where Δp= pEGCG - 
pcontrol. The results shown are representative of at least five independent measurements. 
Fig. 4. Membrane packaging induced by EGCG was enhanced in membranes with lower 
cholesterol content. RBC membranes were pre-treated with 3 mM MβCD during 15 min at 37ºC 
















(plain bars) of EGCG (A). ΔPolarization (Δp) for this system is also shown (B). The results 
shown are representative of at least five independent measurements. 
Fig. 5. Ionic strength and cholesterol content regulates the binding of EGCG to membrane. R18 
was added to membrane suspensions at a 1:1000 probe: phospholipid molar ratio. R18 
fluorescence emission was recorded upon addition of different concentrations of EGCG and 
fluorescence in each sample was expressed as relative to the R18 fluorescence in the absence 
of EGCG. A) Membranes diluted in NaCl-free buffer (●), membranes diluted in 150 mM NaCl 
(■). Besides, membranes were treated with different concentrations of MβCD and R18 
fluorescence was determined after the addition of EGCG. In this case, Stern-Volmer plots are 
presented (B). Regression analysis was perform using GraphPad Prism software (P < 0.001) 
and KSV values were calculated from linear regression: control without dextrin (●), KSV value 
0.0842±0.0053; membranes treated with 0.375 mM MβCD (■), KSV value 0.0996±0.0041; 
membranes treated with 0.75 mM MβCD (▲), KSV value 0.1206±0.0048; membranes treated 
with 1.5 mM MβCD (▼), KSV value 0.1206±0.0048; membranes treated with 3 mM MβCD (◆), 
KSV value 0.1474±0.0065 and membranes treated with 6 mM MβCD (⬣), KSV value 
0.1938±0.0035. Excitation wavelength was set at 540 nm, whereas the emission spectra were 
taken from 560 nm to 650 nm. 
Fig. 6. Infrared spectra of ghosts with different cholesterol content in the presence and the 
absence of ECGC. Main vibrational modes are shown in A) in a buffer subtracted spectrum. 
Carbonyl and amide I’ regions from ~1,800 to 1,500 cm
-1
 (C-F) were analyzed by curve fitting 
due to band overlapping of different vibrational modes. Relative contribution of hydrogen and 
non-hydrogen bonded (red band and blue band) carbonyl groups of control ghosts (C) and 
MβCD-treated ghosts (E) alone and upon incubation with EGCG (D and F, respectively). The 
maximum of the EGCG carbonyl is shown in solution (B) and in the presence of membranes 



















Ionic strength not only increases AChE activity but also enhances the inhibitory 
effect of EGCG 
 
Partial depletion of cholesterol also favors the inhibition of AChE mediated by 
EGCG 
 
Both the increase of the ionic strength and the reduction of membrane cholesterol 
induce a deeper interaction of EGCG with red blood cell ghosts 
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